Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 6, Issue 2, 2007, Pages 101-109

  Brennan, Amanda L ^a,b   Gyi, Khin M ^b   Wood, David M ^a   Johnson, Julie ^a   Holliman, Rick ^a   Baines, Deborah L ^a   Philips, Barbara J ^a   Geddes, Duncan M ^b   Hodson, Margaret E ^b   Baker, Emma H ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Continuous glucose monitoring; Diabetes mellitus; Nasal glucose; Pseudomonas aeruginosa; Staphylococcus aureus

Indexed keywords

GLUCOSE;

ADULT; AIRWAY; ARTICLE; BACTERIAL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; IN VITRO STUDY; INFECTION RISK; LUNG FUNCTION; MALE; NONHUMAN; NOSE SECRETION; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS;

ADULT; BLOOD GLUCOSE; CYSTIC FIBROSIS; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; STAPHYLOCOCCUS AUREUS;

EID: 33947118871     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2006.03.009     Document Type: Article

References (35)

1. Kopito L.E., and Shwachman H. The pancreas in cystic fibrosis: chemical composition and comparative morphology. Pediatr Res 10 (1976) 742-749
2. Soejima K., and Landing B.H. Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytologic studies. Pediatr Pathol 6 (1986) 25-46
3. Moran A. Cystic fibrosis-related diabetes: an approach to diagnosis and management. Pediatr Diabetes 1 (2000) 41-48
4. Finkelstein S.M., Wielinski C.L., Elliott G.R., et al. Diabetes mellitus associated with cystic fibrosis. J Pediatr 112 (1988) 373-377
5. Koch C., Rainisio M., Madessani U., et al., Investigators of the European Epidemiologic Registry of Cystic Fibrosis. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 32 (2001) 343-350
6. Lanng S., Thorsteinsson B., Nerup J., and Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 151 (1992) 684-687
7. Milla C.E., Warwick W.J., and Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 162 (2000) 891-895
8. Wood D.M., Brennan A.L., Philips B.J., and Baker E.H. Effect of hyperglycaemia on glucose concentration of airways secretions. Clin Sci 106 (2004) 527-533
9. Philips B.J., Meguer J.-X., Redman J., and Baker E.H. Factors determining the appearance of glucose in upper and lower respiratory tract secretions. Intensive Care Med 29 (2003) 2204-2210
10. Philips B.J., Redman J., Brennan A.L., Wood D.M., Holliman R., Baines D.L., et al. Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients. Thorax 60 (2005) 761-764
11. Moran A., Hardin D., Rodman D., et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 45 (1999) 61-73
12. Dominguez M.C., de La Rosa M., and Borobio M.V. Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar. J Antimicrob Chemother 47 (2001) 391-398
13. Devaskar S.U., and deMello D.E. Cell-specific localization of glucose transporter proteins in mammalian lung. J Clin Endocrinol Metab 81 (1996) 4373-4378
14. Ishikawa N., Oguri T., Isobe T., Fujitaka K., and Kohno N. Sglt gene expression in primary lung cancers and their metastatic lesions. Jpn J Cancer Res 92 (2001) 874-879
15. Wood D.M., Baines D.L., Woollhead A.M., Philips B.J., and Baker E.H. Functional and molecular evidence for glucose transporters in human airway epithelium. Am J Respir Crit Care Med 169 (2004) A672
16. Barker P.M., Boyd C.A., Ramsden C.A., Strang L.B., and Walters D.V. Pulmonary glucose transport in the fetal sheep. J Physiol 409 (1989) 15-27
17. Saumon G., Martet G., and Loiseau P. Glucose transport and equilibrium across alveolar-airway barrier of rat. Am J Physiol 270 (1996) L183-L190
18. Knowles M.R., Robinson J.M., Wood R.E., et al. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects. J Clin Invest 100 (1997) 2588-2595
19. Kerrebijn J.D., Poublon R.M., and Overbeek S.E. Nasal and paranasal disease in adult cystic fibrosis patients. Eur Respir J 5 (1992) 1239-1242
20. Pier G.B. Peptides, Pseudomonas aeruginosa, polysaccharides and lipopolysaccharides - players in the predicament of cystic fibrosis patients. Trends Microbiol 8 (2000) 247-250
21. Kashket E.R. Proton motive force in growing Streptococcus lactis and Staphylococcus aureus cells under aerobic and anaerobic conditions. J Bacteriol 146 (1981) 369-376
22. Hassett D.J., Sokol P.A., Howell M.L., Ma J.F., Schweizer H.T., Ochsner U., et al. Ferric uptake regulator (Fur) mutants of Pseudomonas aeruginosa demonstrate defective siderophore-mediated iron uptake, altered aerobic growth, and decreased superoxide dismutase and catalase activities. J Bacteriol 178 (1996) 3996-4003
23. Lanng S., Thorsteinsson B., Nerup J., and Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr 83 (1994) 849-853
24. Ma J.F., Phibbs P.V., and Hassett D.J. Glucose stimulates alginate production and algD transcription in Pseudomonas aeruginosa. FEMS Microbiol Lett 148 (1997) 217-221
25. Geerlings S.E., and Hoepelman A.I. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26 (1999) 259-265
26. Kaneshige H. Nonenzymatic glycosylation of serum IgG and its effect on antibody activity in patients with diabetes mellitus. Diabetes 36 (1987) 822-828
27. Reading P.C., Morey L.S., Crouch E.C., and Anders E.M. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol 71 (1997) 8204-8212
28. Reading P.C., Allison J., Crouch E.C., and Anders E.M. Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose?. J Virol 72 (1998) 6884-6887
29. Esposito K., Nappo F., Marfella R., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycaemia in humans: role of oxidative stress. Circulation 106 (2002) 2067-2072
30. Yu W.-K., Li W.-Q., Li N., and Li J.-S. Influence of acute hyperglycaemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. World J Gastroenterol 9 (2003) 1824-1827
31. Straczkowski M., Kowalska I., Nikolajuk A., Dzienis-Straczkowska S., Szelachowska M., and Kinalska I. Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance. Cardiovasc Diabetol 2 (2003) 5
32. Nicolaie T., Zavoianu C., and Nuta P. Pulmonary involvement in diabetes mellitus. Rom J Intern Med 41 (2003) 365-374
33. Brennan A.L., Geddes D.M., Gyi K.M., and Baker E.H. Clinical importance of cystic fibrosis related diabetes. J Cyst Fibros 3 (2004) 209-222
34. Brennan A.L., Wood D.M., Hodson M.E., Geddes D.M., Gyi K.M., and Baker E.H. Blood and airway glucose concentrations in people with cystic fibrosis. J Cyst Fibros 3 (2004) S85
35. Brennan A.L., Johnson J., Holliman R., Philips B.J., and Baker E.H. Glucose at concentrations found in airway secretions increases the growth of Staphylococcus aureus. Am J Respir Crit Care Med 169 (2004) A371